DEUTSCHE BANK AG\ - THERAVANCE INC ownership

THERAVANCE INC's ticker is and the CUSIP is 88338TAB0. A total of 21 filers reported holding THERAVANCE INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 2.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of THERAVANCE INC
ValueSharesWeighting
Q4 2022$2,906,508
-1.4%
2,910,000
-3.0%
0.00%0.0%
Q3 2022$2,947,000
-56.2%
3,000,000
-56.0%
0.00%
-50.0%
Q2 2022$6,726,000
-10.8%
6,825,0000.0%0.00%0.0%
Q1 2022$7,537,000
+22.0%
6,825,000
+20.3%
0.00%
+33.3%
Q4 2021$6,179,000
+13.9%
5,675,000
+12.4%
0.00%0.0%
Q3 2021$5,426,000
-22.7%
5,050,000
-26.9%
0.00%0.0%
Q2 2021$7,020,000
+3.7%
6,908,000
+2.1%
0.00%
-25.0%
Q1 2021$6,772,000
-17.9%
6,768,000
-18.4%
0.00%
-20.0%
Q4 2020$8,245,000
+108.9%
8,290,000
+101.1%
0.01%
+66.7%
Q3 2020$3,946,000
+4.5%
4,123,000
+7.8%
0.00%0.0%
Q2 2020$3,775,000
+6.2%
3,825,0000.0%0.00%0.0%
Q1 2020$3,556,000
+1069.7%
3,825,000
+1158.2%
0.00%
Q4 2019$304,000
+98.7%
304,000
+86.5%
0.00%
Q3 2019$153,000
-87.3%
163,000
-85.8%
0.00%
-100.0%
Q2 2019$1,202,000
+3.4%
1,147,0000.0%0.00%0.0%
Q1 2019$1,163,000
+109.5%
1,147,000
+123.2%
0.00%
Q4 2018$555,000
-90.2%
514,000
-90.8%
0.00%
-100.0%
Q3 2018$5,667,000
-60.5%
5,594,000
-62.2%
0.00%
-50.0%
Q2 2018$14,365,000
+266.7%
14,808,000
+304.6%
0.00%
+100.0%
Q1 2018$3,917,000
-1.8%
3,660,000
-9.2%
0.00%
-33.3%
Q4 2017$3,987,000
-55.5%
4,033,000
-56.0%
0.00%
-50.0%
Q3 2017$8,951,000
-65.6%
9,175,000
-68.0%
0.01%
-68.4%
Q2 2017$26,052,000
-1.9%
28,669,000
+1.9%
0.02%
-5.0%
Q1 2017$26,546,000
+15.2%
28,129,000
+3.4%
0.02%
+5.3%
Q4 2016$23,044,000
-2.9%
27,191,000
-4.1%
0.02%
+11.8%
Q3 2016$23,738,000
+6.0%
28,344,000
+0.0%
0.02%
+6.2%
Q2 2016$22,389,000
-12.0%
28,342,000
-13.2%
0.02%
-15.8%
Q1 2016$25,448,000
-12.2%
32,654,000
-15.7%
0.02%
-5.0%
Q4 2015$28,976,000
+19.8%
38,733,000
+4.9%
0.02%
+5.3%
Q3 2015$24,184,000
+353.5%
36,923,000
+547.7%
0.02%
+533.3%
Q2 2015$5,333,000
+47.8%
5,701,000
+34.0%
0.00%
+50.0%
Q1 2015$3,609,000
-15.6%
4,256,000
-23.0%
0.00%
-33.3%
Q4 2014$4,275,000
-10.6%
5,526,000
+10.4%
0.00%0.0%
Q3 2014$4,780,000
-46.6%
5,006,000
-19.4%
0.00%
-50.0%
Q2 2014$8,956,000
-24.4%
6,212,000
-32.5%
0.01%
-25.0%
Q1 2014$11,849,000
-11.5%
9,200,000
-0.2%
0.01%
-20.0%
Q4 2013$13,388,000
-10.5%
9,215,000
+0.2%
0.01%
-9.1%
Q3 2013$14,959,0009,200,0000.01%
Other shareholders
THERAVANCE INC shareholders Q4 2015
NameSharesValueWeighting ↓
PIPER SANDLER & CO. 4,233,000$4,227,9204.38%
Monashee Investment Management LLC 4,000,000$4,034,3941.74%
Radcliffe Capital Management, L.P. 27,688,000$27,654,7740.88%
OAKTREE CAPITAL MANAGEMENT LP 19,354,000$19,403,3530.20%
WOLVERINE ASSET MANAGEMENT LLC 14,676,000$14,631,6300.15%
SSI INVESTMENT MANAGEMENT LLC 2,275,000$2,272,2700.14%
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 2,870,000$2,8670.02%
D. E. Shaw & Co., Inc. 11,336,000$11,304,6850.01%
Russell Investments Group, Ltd. 4,171,000$4,211,0600.01%
TORONTO DOMINION BANK 2,450,000$2,4420.00%
View complete list of THERAVANCE INC shareholders